申请人:Centrexion Therapeutics Corporation
公开号:US11254659B1
公开(公告)日:2022-02-22
The invention provides capsaicinoid prodrug compounds (e.g., prodrugs of resiniferatoxin, tinyatoxin, iodoresiniferatoxin, and related compounds), pharmaceutical compositions, and their use in the treatment of medical conditions, such as pain, and in agonizing TRPV1 activity.
本发明提供了辣椒素原药化合物(例如,松脂铁毒素、微小铁毒素、碘松脂铁毒素和相关化合物的原药)、药物组合物,以及它们在治疗疼痛等病症和激动TRPV1活性方面的用途。